EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Lokaler Crossref-Datenbestand · journal-article

Dual-mode carbon dioxide laser (continuous and fractional) with 1540 nm non-ablative fractional laser and topical sirolimus in lymphangioma circumscriptum

Ojas Dipak Kulkarni, Ruta Joshi Kulkarni, Charu Garg, Dipak Shridhar Kulkarni

Journal of Cutaneous and Aesthetic Surgery · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Lymphangioma circumscriptum (LC) is a rare lymphatic malformation majorly localized in the skin. We report a case of 12-year-old girl with LC which was simultaneously treated with carbon dioxide laser (10600 nm) and 1540 nm non-ablative fractional laser, followed by topical sirolimus during and after the procedure for a total of seven sessions. Simultaneous combination of 1540 nm non-ablative fractional and CO2 laser as a targeted therapeutic strategy for LC has been limited to one case in the past, but without the use of sirolimus. This report highlights the application and immediate outcomes of this combined use of different lasers along with topical sirolimus, underscoring its potential relevance for future clinical practice and research.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Ojas Dipak Kulkarni, Ruta Joshi Kulkarni, Charu Garg, Dipak Shridhar Kulkarni
Quelle
Journal of Cutaneous and Aesthetic Surgery
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
0974-5157, 0974-2077
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Ojas Dipak Kulkarni, Ruta Joshi Kulkarni, Charu Garg, Dipak Shridhar Kulkarni (2026). Dual-mode carbon dioxide laser (continuous and fractional) with 1540 nm non-ablative fractional laser and topical sirolimus in lymphangioma circumscriptum. Journal of Cutaneous and Aesthetic Surgery. https://doi.org/10.25259/jcas_102_2026
RIS BibTeX CSL-JSON